<DOC>
	<DOCNO>NCT00994760</DOCNO>
	<brief_summary>The aim study evaluate safety efficacy intranasal fentanyl spray cancer patient four week , especially cancer-related breakthrough pain ( BTP ) attack . The fentanyl spray apply nose metered-spray device . The study provide data pharmacoeconomic efficiency intranasal fentanyl spray .</brief_summary>
	<brief_title>Efficacy Tolerability Intranasal Fentanyl Spray Treatment Breakthrough Pain Cancer Patients Older Than 18 Years</brief_title>
	<detailed_description />
	<mesh_term>Breakthrough Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Inclusion criterion : decision start treatment intranasal fentanyl spray write informed consent Exclusion criterion : criterion define Summary Product Characteristics ( Fachinformation Chapter 4.3 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>intranasal fentanyl spray</keyword>
</DOC>